Literature DB >> 10028688

High-sensitivity analysis and sequencing of peptides and proteins by quadrupole ion trap mass spectrometry.

A Marina1, M A García, J P Albar, J Yagüe, J A López de Castro, J Vázquez.   

Abstract

This paper describes experience with the commercially available LCQ quadrupole ion trap mass spectrometer applied to the off-line analysis of peptides and proteins. The standard front end of the electrospray probe was replaced with a micromanipulator which, with the aid of a magnifying device, allowed the use of a variety of miniaturized spraying interfaces. The low sample consumption and extended analysis times of these devices were ideally suitable to obtain improved results in terms of sensitivity and mass accuracy. This needed a careful optimization of the number of ions stored inside the trap (ion target parameter) and required spectrum averaging of many scans. A method is presented for the mathematical fitting of ZoomScan spectra to theoretical isotopic distributions, which allowed the mass determination of large peptides with more accuracy than that achieved by conventional deconvolution algorithms. A very simple on-line desalting configuration is also described which needed no external micro-high-performance liquid chromatographic pumps, and can be easily mounted using the built-in syringe delivery system of the LCQ. This set-up allowed extended analysis times of 'in-gel' protein digests in subpicomole amounts. Finally, the multiple fragmentation capabilities of the ion trap were found to be extremely useful for the analysis of peptide modifications such as phosphorylation and for sequencing individual peptides from highly complex MHC-bound peptide pools.

Mesh:

Substances:

Year:  1999        PMID: 10028688     DOI: 10.1002/(SICI)1096-9888(199901)34:1<17::AID-JMS746>3.0.CO;2-6

Source DB:  PubMed          Journal:  J Mass Spectrom        ISSN: 1076-5174            Impact factor:   1.982


  8 in total

Review 1.  Mass spectrometry innovations in drug discovery and development.

Authors:  D I Papac; Z Shahrokh
Journal:  Pharm Res       Date:  2001-02       Impact factor: 4.200

2.  Characterization of natural peptide ligands from HLA-DP2: new insights into HLA-DP peptide-binding motifs.

Authors:  Gema Díaz; Benito Cañas; Jesús Vazquez; César Nombela; Javier Arroyo
Journal:  Immunogenetics       Date:  2004-11-24       Impact factor: 2.846

3.  Specific interaction of heterogeneous nuclear ribonucleoprotein A1 with the -219T allelic form modulates APOE promoter activity.

Authors:  Mónica Campillos; José Ramón Lamas; Miguel Angel García; María Jesús Bullido; Fernando Valdivieso; Jesús Vázquez
Journal:  Nucleic Acids Res       Date:  2003-06-15       Impact factor: 16.971

4.  Trypanosoma cruzi mitochondrial malate dehydrogenase triggers polyclonal B-cell activation.

Authors:  C L Montes; E I Zuñiga; J Vazquez; C Arce; A Gruppi
Journal:  Clin Exp Immunol       Date:  2002-01       Impact factor: 4.330

5.  Leaving group and gas phase neighboring group effects in the side chain losses from protonated serine and its derivatives.

Authors:  G E Reid; R J Simpson; R A O'Hair
Journal:  J Am Soc Mass Spectrom       Date:  2000-12       Impact factor: 3.109

6.  Pulsed Nano-Electrospray Ionization: Characterization of Temporal Response and Implementation with a Flared Inlet Capillary.

Authors:  Jared M Bushey; Desmond A Kaplan; Ryan M Danell; Gary L Glish
Journal:  Instrum Sci Technol       Date:  2009       Impact factor: 1.584

7.  Infection with Salmonella typhimurium has no effect on the composition and cleavage specificity of the 20S proteasome in human lymphoid cells.

Authors:  Miguel Marcilla; José Antonio López de Castro; José G Castaño; Iñaki Alvarez
Journal:  Immunology       Date:  2007-05-09       Impact factor: 7.397

8.  An N-acetylated natural ligand of human histocompatibility leukocyte antigen (HLA)-B39. Classical major histocompatibility complex class I proteins bind peptides with a blocked NH(2) terminus in vivo.

Authors:  J Yagüe; I Alvarez; D Rognan; M Ramos; J Vázquez; J A de Castro
Journal:  J Exp Med       Date:  2000-06-19       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.